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Abstract: Total mesorectal excision (TME), a revolutionary change and a milestone in the history of 
surgical treatment for rectal cancer, has been widely recognized as the gold standard and is now a routine 
procedure. The concept of complete mesocolic excision (CME) was proposed based on the similar 
philosophy as TME, aimed to achieve better surgical quality and improve the oncological outcomes of colon 
cancer. In recent years, many surgeons have increasingly adopted the principle and conducted clinical trials 
to verify the effect of CME; however, whether CME should be used as the standard surgical technique is still 
controversial. In this article, we reviewed and updated the literature. Experts in this field from nine countries 
were invited to complete a questionnaire concerning CME, with the aim to illustrate the embryological and 
anatomical basis and reach a consensus of the current situation and future of CME.
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Introduction
The concept of total mesorectal excision (TME), proposed 
by Heald over 20 years ago, marked a revolution in the 
radical treatment of rectal cancer (1,2). Although essentially 
based on non-randomized, retrospective or historical 
comparisons, TME is widely recognized today as the 
gold standard for radical treatment of middle and low 
rectal cancer (3). Before this concept was envisioned and 
popularized, carcinological outcomes for colon cancer 
resection were long thought to be better than those for 
rectal cancer (4,5), but with widespread application of 
TME, the gap between the two narrowed (6), indirectly 
indicating the TME had a positive effect on outcome. In 
contrast to rectal cancer, progress in terms of oncological 
endpoints has been slow and marginal for surgical treatment 
of colon cancer.
Several authors have underlined the value they gave to 
radical, complete intra-fascial, excision for gastro-intestinal 
cancer. As early as 1909, Jamieson and Dobson proposed: 
“no operation for malignant disease can be considered 
complete without the removal of lymphatic glands”, 
and further, “The ideal operation consists in removing a 
considerable length of gut on each side of the growth, the 
primary glands, together with the vessels running to them 
from the gut, and the tissues in which these vessels lie—i.e., 
the so-called “lymphatic area“ (7), interpreted as “sufficient 
excision of the bowels, complete resection of the mesocolon 
en-bloc, and central ligation of the vessels” (8). In 2003, 
Bokey et al. (9) proposed the term of “‘anatomical dissection 
of the colon” (ADC), for what they and many others 
believed was already being performed in radical colonic 
surgery (10,11). In 2009, Hohenberger et al. proposed 
the name of complete mesocolic excision (CME) (12), 
corresponding to the terminology most widely used today, 
and that we will maintain in this report. Well beyond a 
simple disparity in terminology, however, the question of 
whether CME represents a revolutionary approach for 
radical surgery and can improve oncologic outcome in 
colorectal cancer still remains to be answered. 
CME has been performed via laparotomy for many 
years, but morbidity has been reported to be high in non-
expert centers (13-15). Minimal access colorectal surgery 
has matured steadily over the last decades (16): hence the 
natural spin-off was whether CME can be performed safely 
and adequately using minimal access techniques.
A previous consensus conference on CME was published 
in 2014 (17). The authors proposed “there are sound 
oncological hypotheses for a more radical approach [to 
colonic cancer] than has been common up to now”. As 
for laparoscopic CME, the consensus was “Laparoscopic 
resection appears to be equally well suited for resection as 
open surgery” (17).
In this article we propose to review the embryological 
and anatomical rational behind CME and update the 
literature concerning clinical experience [only 5 references 
(out of 86) in the previously mentioned consensus 
conference were from 2013 or later] (17), in order to place 
CME in perspective in 2018.
The questions we intend to address include:
(I) Have the embryonic and anatomic bases of CME 
been sufficiently delineated?
(II) Has the CME technique been adequately 
described? (laparotomy, laparoscopy, robotic-
assisted surgery)
(III) I s  C M E  f e a s i b l e  a n d  s a f e  ( l a p a r o t o m y, 
laparoscopy, or robotic-assisted surgery) in all 
patients and by all?
(IV) What are the specific oncologic outcomes of 
CME?
(V) How does CME fare compared to D3 resections?
(VI) Are there specific indications for CME? (Should 
it be performed in all patients, is it necessary for 
all stages?)
(VII) What are the future perspectives for CME?
(VIII) Can CME be considered the gold standard in 2017?
Several key questions were formulated and submitted to 
the experts and answers compiled. An extensive literature 
research was performed (WU and AF). MEDLINE, 
Embase, PubMed, Cochrane, and Scopus libraries were 
queried, and all papers analyzing CME or D3 resection of 
colonic cancer written in English and published from 1980 
were considered for inclusion. Related articles found in the 
reference lists of the studies retrieved for full-text review 
were used to complete the search.
Several revised versions of the first draft of the 
manuscript were circulated through electronic mail for 
critical analysis and modification until obtaining the final 
version that was approved by all authors in February 2018.
Have the embryonic and anatomic bases of CME 
been sufficiently delineated?
Consensus
Number of answers =15 (14 yes/1 no)
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Literature review
Both the colonic mesentery and the mesorectum are 
derived from the dorsal mesentery. During intra-uterine 
growth, this mesentery surrounds the entire future colon 
and attaches it to the posterior abdominal wall. Treves 
et al. (18) described the dorsal mesentery of the left and 
right colons as being “fixed” to the retroperitoneal wall and 
then, by “fusing” with the retroperitoneal membrane, the 
left and right colonic mesenteries finally “disappeared”. 
Since the transverse colon and the sigmoid mesocolon 
continue to exist even in adulthood, Treves et al. believed 
that the colonic mesentery was “discontinuous” in 
adults (18). Thus, in most textbooks on embryology and 
anatomy, the ascending and descending colons have been 
and continue to be described as “retroperitoneal” organs 
whereas the transverse colon and the sigmoid colon are 
considered “intraperitoneal” organs (19).
However, over the years, it became apparent that 
there was a natural anatomical plane between colon and 
retroperitoneum enabling the operator to detach the left 
or right colon and isolate the entire colonic mesentery, 
so achieving complete resection of relevant blood and 
lymphatic vessels, lymph nodes, and adipose tissues. Toldt 
et al. (20) described that the left and right colonic mesenteries 
persisted through adulthood: these mesenteries separate 
the retroperitoneal wall via a discrete layer of connective 
tissue. This proper mesangial layer, the lamina mesenteria 
propria would later be known as the Toldt’s fascia (21), 
confirmed later by others (22,23) who argued, compared 
with Treves, that this idea was closer to the “real world” 
findings in surgical operations. In 2014, Culligan et al. (24) 
investigated the colonic mesentery with electron microscopy 
and confirmed the presence of Toldt’s fascia between the 
mesothelial cell layer of the posterior aspect of the left and 
right colonic mesenteries and the retroperitoneum. 
After extensive anatomic and histological studies, 
Culligan et al. (23,24) stated (I) the mesocolon was 
continuous from ileocecal to the rectosigmoid; (II) a 
mesenteric confluence is found at the ileocecal and 
rectosigmoid junction as well as at the hepatic and 
splenic flexures; (III) each flexure (and ileocecal junction) 
is composed of a complex of peritoneal and omental 
attachments to the colon centered on a mesenteric 
confluence; (IV) the proximal rectum originates at the 
confluence of the mesorectum and mesosigmoid and 
is continuous with the mesorectum; and (V) a plane 
occupied by Toldt’s fascia separates the entire apposed 
mesocolon from the retroperitoneum. In other terms, 
the mesocolon and retroperitoneum are separated by 
two mesothelial layers with a connective tissue layer 
between them (15), corresponding to the CME plane of 
dissection (23).
Accordingly, the colonic mesentery described contains 
the blood and lymphatic vessels and nodes emanating from 
and going to the corresponding colonic segments (25,26). 
Thus, combined with more contemporary descriptions 
(27,28), the embryologic and anatomic bases for clear 
identification and excision of the entire mesocolon have 
been laid down. 
Recently there has been a move to standardize the 
terminology, both of the anatomy and of the corresponding 
colectomies (29-31). For the former, terms such as visceral 
and parietal fascia, anterior renal fascia, anterior pararenal 
space, mesocolic plane, intramesocolic plane and muscularis 
propria plane surgery continue to be used. The anatomic-
based nomenclature proposed by Coffey et al. (27) includes 
(I) operation titles used for resectional colonic surgery (i.e., 
total right mesocolectomy), (II) avoiding disruption of the 
mesenteric package by dissection in anatomic planes (i.e., 
colo- and mesofascial planes) and (III) standard dissection 
technique to ensure complete and intact mesenterectomy 
(i.e., CME).
Ignjatovic and Bergamaschi have proposed the term of 
“extended D3 mesenterectomy” to include the dissection of 
all D3 lymph nodes (31).
The vascular anatomy of the colon also has its 
importance as many authors have highlighted the extreme 
variability of arterial and venous colonic vasculature and 
how these variations may influence the operative tactic, 
and lymph node yield, particularly in CME or D3 right 
colectomy (31-34).
Has the CME technique been adequately 
described? 
Consensus
Number of answers =15
 Laparotomy (15 yes)
 Laparoscopy (14 yes/1 no)
 Robotic-assisted surgery (8 yes/7 no)
Number of answers =13
	 Single port (4 yes/9 no)
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Literature review
CME via laparotomy has been described in detail in 
Australia (9), Germany (12) and the United States (35). 
Slight modifications have been made including:
	 The timing of duodenal Kocher maneuver (9,36);
	 Removal of sub-pyloric and over the pancreatic 
head lymph nodes (17);
	 R e m o v a l  o f  l y m p h  n o d e s  a l o n g  t h e  l e f t 
gastroepiploic arcade (17,36).
The laparoscopic technique was detailed by several 
authors (37-43). The technique described by Shin et al. (37) 
is a mix of principles described by Bokey et al. (9), 
Hohenberger et al. (12) and the recommendations made by 
the Japanese guidelines (2,44). 
Several authors have highlighted the importance of 
the starting point and order of dissection. Zhu et al. (39) 
emphasized that three anatomic planes must be found. The 
first surgical plane is the fascia space between the posterior 
aspect of the ascending mesocolon and the prerenal fascia, 
to the right of Toldt’s space plane. The second plane 
separates the posterior ascending mesocolon and the 
anterior aspect of the pancreatic head and duodenum fascia. 
The third surgical plane is formed by the posterior aspect 
of the right-sided transverse mesocolon and the right-sided 
dorsal mesogastrium fusion fascia.
Likewise, Spasojevic et al. (45,46) defined the “D3 
area”: (I) the cranial border runs 5 mm proximal to the 
line connecting the origins of the gastrocolic trunk of 
Henlé (GTH) and the middle colic artery (MCA); (II) the 
medial border runs along the left-hand side of the superior 
mesenteric artery (SMA); (III) the caudal border runs 5 mm 
distal to the line connecting the origin of the ICA and the 
confluence of ileocolic vein to the SMV; and (IV) the lateral 
border runs 1 cm parallel to the right-hand side of the SMV.
Most authors perform CME with a lateral to medial 
approach, Matsuda et al. advised a cranial approach for easier 
access to the middle colic vessels (40). Benz et al. proposed to 
commence central mesentery dissection starts posteriorly at 
the level of the 4th part of the duodenum (41,42).
Central vascular ligation (CVL) is the cornerstone of 
radical excision principles (12,28,45-51). The goal of CVL 
is to remove as much lymph nodes and associated vascular 
structures in a vertical or ascending direction potentially 
removing lymph node metastases, as well as vascular and 
neural invasion of the regional drainage area (12,17).
The robotic technique was described for both right and 
left colectomy (16,52-55). All of these studies have suggested 
that robotic CME can potentially facilitate the difficulties 
encountered in laparoscopic CME and intra-corporeal 
anastomosis, especially for the novice. In the systematic 
review by Trastulli et al. (55), the authors analyzed 12 
studies (total of 4,148 patients) of which 10 indicated their 
approach to mobilization (mostly medial to lateral), with 
nearly 50% of intra/extracorporeal and hand-sewn or 
mechanical anastomoses. They found that robotic surgery 
was associated with longer operative time and higher costs 
compared to laparoscopic colectomy, but was feasible. 
However, as these findings were based on observational 
studies including operations labeled as “colectomy” and the 
proportion of CME or D3 colectomies was unknown, it is 
impossible to extrapolate these conclusions to CME or D3.
Ma et al. (56) gave a detailed description of the single port 
technique, compared with their standard 5-port technique. 
Is CME feasible and safe (via laparoscopy or 
other minimal access techniques) in all patients 
and by all?
Consensus
Number of answers =15
	 Feasible via laparotomy (15 yes)
	 Feasible via laparoscopy (15 yes)
	 Feasible via robotic (13 yes/2 no)
	 Feasible via single port (9 yes/5 no/1 no experience)
Number of answers =14
	 Safe  (acceptable  morbidi ty/morta l i ty)  v ia 
laparotomy (14 yes)
	 Safe  (acceptable  morbidi ty/morta l i ty)  v ia 
laparoscopy (14 yes)
	 Safe (acceptable morbidity/mortality) via robotic 
(10 yes/3 no /1 no experience)
	 Safe (acceptable morbidity/mortality) via single 
port (5 yes/7 no/1 no experience/1 not sure)
	 Feasible in the obese? (8 yes/2 no/4 difficult)
	 Can be performed by all surgeons? (3 yes/10 no/1 
not sure)
	 Should be performed by colorectal surgeons only? 
(7 yes/6 no: 1 not sure)
	 Should be performed laparoscopic experts? 
(12 yes/1 no/7 not sure) 
Literature review
Bokey et al. (57) reported the outcome of 779 of 905 
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patients who had a potentially curative resection with the 
previously described “ADC”: overall, the rates of surgical 
complications were “low” (the exact percentage was not 
found) and in particular the anastomotic leakage rate was 
1.6% (14/864 restorative procedures).
Is CME feasible via laparoscopy?
Continuous progress in technology [application of high-
definition (HD) and three-dimensional (3D) and other 
camera systems, among others] has led to claims of 
improved precision in lymph node dissection and vascular 
skeletonization (36,39).
Several single institution non-comparative small studies 
have reported that laparoscopic CME or D3 resection 
was feasible and did not compromise patient safety 
(37,43,44,58-64).
Regarding the comparative studies, Huang et al. (65) 
provided clinical data from 102 patients with right colon 
cancer who underwent CME (53 by laparoscopy; 49 by 
open). No conversions were necessary. There was no 
statistically significant difference found operative time 
or postoperative complications, but laparoscopic CME 
was associated with less intraoperative blood loss, shorter 
duration of hospital stay. 
Storli et al. (66) comparing the data of 251 patients 
who had undergone either laparoscopic or open CME, 
found that incidences of complications were lower in 
the laparoscopic CME group. West et al. (67) compared 
the specimens obtained via laparoscopic CME or open 
CME and found that there was no statistically significant 
difference between the two groups. More recently, Kim 
et al. (68) compared the results between 99 patients who 
underwent open surgery with 116 patients undergoing 
laparoscopy and found that there were fewer postoperative 
complications, reduced time to soft diet, and reduced length 
of hospital stay with laparoscopic CME.
In the only randomized trial today (69,70), including 
1,057 patients, conversion to open surgery was necessary in 
29 (5.4%) patients.
Chyle leakage has been cited as a possible complication 
associated with extensive (CME) dissection compared to the 
standard approach. Bae et al. (71) found that chyle leakage 
occurred less frequently in the laparoscopic group than in 
the open group (3.5% vs. 14.1%; P=0.015); they attributed 
this difference to the use of an ultrasound scalpel or vessel-
sealing devices for peri-vascular lymph node dissection and 
a magnified view provided by laparoscopy.
Is CME feasible via single port?
Some studies have suggested that reduced or single port 
laparoscopic CME was feasible with the potential advantages 
of reduced postoperative pain and better cosmesis (56,72), 
but both were non-comparative observational studies. 
Is CME safe?
Morbidity and mortality have been summarized in three 
systematic reviews (28,38,73) with considerable overlap. 
Killeen et al. (38) analyzed 21 non-randomized, mainly 
retrospective, studies including 5,246 patients: operative 
mortality rate was 3.2% and cumulative morbidity rate was 
21.5%. About one third of the operations (33.5%) were right 
colectomies, more than half (52.5%) were left colectomies, 
while the remaining were transverse colectomies (4.9%) or 
unspecified (9.1%). This review included both comparative 
and non-comparative studies. Two years later, Athanasiou 
et al. (73) compared the outcomes of eight studies [one 
randomized trial (69,70) and seven non-randomized trials 
comparing open vs. laparoscopic CME or D3 resections 
(66,71,74-78)], all published last 10 years. Of note, only 
one study (76) was included in both reviews. This second 
review did not find any statistically significant difference in 
short-term mortality, anastomotic leakage, ileus or deep/
surgical site infection/abscess. There was a trend for longer 
operative time (P=0.05) and shorter duration of hospital 
stay (P=0.09) with the laparoscopic approach. Laparoscopic 
right hemicolectomy had a lower surgical site infection 
rate (P=0.005) compared with open CME. Siani et al. (28) 
reviewed a mix of comparative and non-comparative studies, 
and finally did not come to any groundbreaking conclusions. 
All three reviews concluded that, based on the current 
evidence in 2014 and 2016, the laparoscopic technique 
appeared to be feasible and at least as safe (morbidity not 
statistically significantly different) as the open technique 
whether used to perform D3 lymphadenectomy or CME 
for colonic cancer. The only randomized trial (69), 
however, observed that thirty day morbidity was statistically 
significantly lower in the laparoscopic group [76/533 
(14.3%) vs. 117/524 (22.3%)] probably explaining why 
duration of stay was shorter in this group.
One further study (not included in any of the three 
systematic reviews), a non-randomized study from 
Korea, Kim et al. (68), comparing elective CME either by 
open surgery (n=99) or laparoscopy (n=116) found that 
laparoscopic CME conferred short-term benefits in terms 
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of lower rates of postoperative complications, reduced time 
to soft diet, and reduced length of hospital stay.
Siani et al. recently reported one of the largest series 
(600 cases) of laparoscopic right colectomy with (79): 
mortal i ty  was  0 .5% while  morbidity  was  35.5%. 
Readmission and reoperation rates were 5.1% (31 patients; 
81% for Dindo-Clavien grade I and II complications) and 
2.5% (10 cases for anastomotic leakage and 5 for intestinal 
obstruction), respectively.
Chyle leakage has been cited as a possible complication 
associated with extensive (CME) dissection compared to the 
standard approach. Bae et al. (71) found that chyle leakage 
occurred less frequently in the laparoscopic group than in 
the open group (3.5% vs. 14.1%; P=0.015); they attributed 
this difference to the use of an ultrasound scalpel or vessel-
sealing devices for peri-vascular lymph node dissection and 
a magnified view provided by laparoscopy.
Is CME safe with robotics?
While laparoscopic colectomy has been compared to robotic 
colectomy in several studies and summarized in meta-
analyses (53,55), there is little if any literature specifically 
comparing laparoscopic to robotic CME or even D3 
colectomy. The reduction of morbidity could not be shown 
in right colectomy (52); better vision was claimed for left 
colectomy but there was no real comparison (54). In their 
systematic review, Trastulli et al. (55) found that robotic 
surgery was associated with less intraoperative blood loss 
(MD −16.82, P<0.00001) with a lower incidence of overall 
postoperative complications (OR 0.74, P=0.02) and wound 
infections (RD −0.02, P=0.03) compared to laparoscopic 
colectomy. No statistically significant differences were 
found in the anastomotic leak, or conversion to open 
surgery rates. However, once again as these findings were 
based on observational studies only, and the proportion of 
CME or D3 colectomies was unknown, it is impossible to 
extrapolate these conclusions to CME or D3.
Is obesity a problem?
One argument often put forward in the discussion why 
laparoscopic D3 resection (or by extension laparoscopic 
CME) is performed more often in the East (vs. the West) 
has been the BMI (14). Several papers have looked at 
the influence of obesity on the outcome of colectomy 
but few have specifically concerned laparoscopic CME 
(9,80-86). In a systematic review and meta-analysis of 13 
observational studies (again without any specific reference 
to CME) looking at the influence of obesity (defined as 
BMI ≥30 kg/m2 in the Western population, ≥25 kg/m2 in the 
Asian population) on laparoscopic colorectal resections (80), 
the authors concluded that laparoscopic colorectal cancer 
operations were more technically challenging in the obese 
as the conversion and postoperative complication rates were 
higher compared to non-obese patients. Notwithstanding, 
there were no statistically significant differences found 
between the two groups as concerned oncologic adequacy.
Of interest, however, when they compared the Asian 
publications (where the proportion of D3 resections should 
be high), they also found increased lymph node retrieval in 
the non-obese compared to the obese. For the authors, this 
observation may be due to the increased technical difficulty 
in obese compared to non-obese patients or due to an 
inherent difference in in vivo lymph nodes between these 
two groups. To date, the association between obesity and 
adequacy of lymph node retrieval remains unclear (86).
Zou et al. (87) recommended the lateral to medial (caudal 
to cranial) approach in the obese with a thick mesentery, 
stating that the retroperitoneal approach to the vessels was 
easier from behind. 
Functional outcome
In the prospective multicenter trial (‘‘Safe Radical D3 Right 
Hemicolectomy for Cancer through Preoperative Biphasic 
Multi-detector Computed Tomography’’) in which all soft 
tissue surrounding the superior mesenteric vessels from 
the level of the middle colic artery to that of the ileocolic 
artery was removed, Thorsen et al. (88) compared bowel 
function [Diarrhea Assessment Scale (DAS)] and quality 
of life (Gastrointestinal Quality of Life Index (GIQLI) in 
two consecutive cohorts (n=49 in each) undergoing right 
colectomy, one with and the other without D3 extended 
mesenterectomy. The authors concluded that small bowel 
denervation after right colectomy with D3 extended 
mesenterectomy leads to increased bowel frequency but 
does not impact gastrointestinal quality of life and as DAS 
scores bowel frequency scores were lower when jejunal 
arteries were cranial to the D3 dissection area, individual 
anatomical variants can affect postoperative bowel function 
differently despite standardized surgery (88).
It is difficult to state whether CME (or D3) can be 
performed adequately, safely and via laparoscopy in 
nonspecialized centers. In Denmark, this was the case for 
three of the four units specialized in colorectal surgery 
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and may explain some of the differences observed in 
outcome (13). Indeed, many surgeons in the Western 
sphere have been reluctant to apply D3 dissection in the 
treatment of colorectal cancer considering the surgical 
difficulty and due to increased postoperative complications 
(13-15) including more splenic (3.2% vs. 1.2%; P=0.004) 
and superior mesenteric vein (1.7 vs. 0.2%; P<0.001) 
injuries, sepsis with vasopressor requirement (6.6% vs. 3.2%; 
P=0.001) and postoperative respiratory failure (8.1% vs. 
3.4%; P<0.001) (13).
What are the specific oncologic outcomes of 
CME?
Consensus
Number of answers =15
	 Better lymph node yield (12 yes/1 no/2 not sure)
	 Extended length of resection (9 yes/4 no/2 not 
sure)
	 Better staging (11 yes/2 no/2 not sure)
	 Lower local recurrence rates (10 yes/3 no/2 not 
sure)
	 Improved survival (10 yes/3 no/2 not sure)
Literature review
Hohenberger et al. [1,438 colon cancer patients of which 
1,329 were followed for a median of 103 (range, 1–335) 
months] in their historical comparison, found that 5-year 
recurrence rate decreased from 6.5% [1978–1984] to 3.6% 
[1995–2002] and 5-year survival increased from 82.1% 
[1978–1984] to 89.1% [1995–2002] (12).
However, the duration of the Hohenberger study was 
24 years (1978–2002 with the observation period ending 
in 2006), during which the emergence of neo-adjuvant, 
adjuvant and targeted therapies, evolving operative and 
anesthesia techniques, peri-operative care may potentially 
have impacted the results. Moreover, were excluded from 
analysis those patients who died, those with unknown tumor 
status, those with associated inflammatory bowel disease or 
familial adenomatous polyposis coli, R1 resections, patients 
with synchronous or previous cancers, patients having 
undergone neoadjuvant therapy or those where histological 
data were missing (at least 200 patients).
Olofsson et al. (89) identified 2084 patients with right-
sided cancer in the Swedish Colorectal and found no 
statistically significant differences in 3-year overall survival, 
3-year disease-free survival and local recurrence rate 
according to the level of ligation of the ileocolic, middle 
colic and right colic vessels. Only a limited number of 
case studies (9,12,79,90) and one comparative study (91) 
have suggested that CME could significantly lower local 
recurrence rates and increase survival. Of note, in the 
retrospective large-scale study in Denmark (91), the 4-year 
disease-free survival rate (all UICC stages confounded) in 
the CME group was 85.8% (95% CI: 81.4–90.1), which was 
significantly longer than that in the conventional resection 
group (75.9%) (72.2–79.7) (P=0.0010). Multivariate Cox 
regression analysis indicated that CME was a significant 
and independent prognostic factor for a higher disease-free 
survival rate, and this finding also applies to patients with 
UICC stage II/III colon cancer (91).
In the ADC report by Bokey et al. (57) the local 
recurrence rate was 2.1% (95% CI: 1.3–3.4), the systemic 
recurrence rate was 10.2% (95% CI: 8.1–12.7), 5-year 
overall survival was 76.2% (95% CI: 73.0–79.0) and cancer-
specific survival rate was 89.8% (95% CI: 87.3–91.9). R0 
status was confirmed in 883/905 patients (97.6%; 95% 
CI: 96.4–98.5). Of note, the width of the confidence 
intervals in this study was quite narrow, attesting to the 
robustness of the results, but it remains a single-center 
(although expert) non-comparative experience.
In another non-randomized historical comparison, 
Galizia et al. compared the outcomes of patients who 
had undergone CME for right colonic cancer (n=45) to 
a historical group having undergone conventional right 
hemicolectomy (n=58) (92). At 4-year follow-up, local 
recurrence never developed in the CME but in 21% of the 
historical control group, disease-specific survival improved 
(93.3% vs. 75.9%; P=0.0356), while there was no statistically 
significant difference found in distant metastasis (13.3% 
and 13.7%, respectively). There were, however, statistically 
significantly more early stage cancers in the CME group. 
Nonetheless, the bias of a historical comparison does not 
allow any conclusions.
In conclusion, it is not possible today to state with formal 
evidence that oncological outcomes are better than those for 
traditional colectomy; more evidence from robust studies is 
needed to clarify the long-term effectiveness of CME. 
Open vs. laparoscopic resections
In the meta-analysis performed by Athanasiou in 2016 (73), 
no statistically significant difference was found in overall 
survival, disease-free survival, local recurrence and distant 
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metastases between the two approaches. However, of note, 
once again, no distinction was made between the CME and 
D3 resections that were analyzed together.
The long term results of the only randomized trial 
comparing laparoscopic and open CME (non-inferiority 
study) were published just recently (70): the authors were 
unable to show that overall survival (main endpoint) after 
laparoscopic D3 was not inferior to open D3 with any 
statistically significant difference. Because overall survival 
did not differ statistically significantly between the two 
groups, and was actually better than expected, the authors 
concluded that laparoscopic surgery with Japanese D3 
dissection appeared to be acceptable as a treatment option 
for patients with stage II or III colon cancer.
Quality of the specimen
Similar to the grading system of completeness of TME 
excision (5), Quirke, West and collaborators have developed 
a grading system based on the grading system used in the 
MRC CR07 trial for rectal cancer (93):
	 Mesocolic plane of resection: “Good” surgery, 
performed along mesofascial interface; producing 
intact,  inviolate mesocolon with a smooth 
peritoneal surface;
	 Intramesocolic plane of resection: “Moderate” 
characterized by irregular breaches in the 
mesocolon, none reaching the muscularis propria 
of the colon; 
	 Muscularis Propria plane of resection: “Poor” 
characterized by disruption of the mesocolon, with 
breaches the visceral muscularis propria.
West et al. (26) assessed 399 specimens obtained from 
surgeries for colon cancer and found that specimens 
resulting from dissection along the colonic mesentery 
plane had a statistically significantly larger area of resected 
mesentery and distance between the mesenteric margin 
and proper muscular layer than in the specimens obtained 
via surgeries that had damaged the colonic mesentery or 
entered the proper muscular layer (i.e., incomplete colonic 
mesentery). Based on these findings, West et al. elaborated 
a tissue morphometry procedure (25) in which the distance 
from the tumor and the closest bowel wall to the high 
vascular ties, the length of the large and small bowel, and 
the area of mesentery resected are quantified using the 
CellD image analyzer (Olympus, Tokyo, Japan) of high-
resolution digital color photographs. West et al. (67) then 
compared the quality of specimen from laparoscopic CME 
to open CME in published series by grading the plane of 
resection (26) and tissue morphometry (25). They found 
(I) the quality of the specimen was similar between groups, 
although the lymph node yield was statistically significantly 
lower in the laparoscopic group (difficult to explain given 
the similarities in specimen quality); (II) intact (“good”) 
colonic mesentery or proper muscular layer was statistically 
significantly associated with longer 5-year survival (67).
However, the relation between the quality of CME and 
increased survival remains unclear (94).
In addition, quality assessment of the specimen should 
be unified. The resected colon and mesentery should be 
measured by an experienced surgeon prior to fixation.
Gouvas  e t  a l .  a l so  compared  spec imens  w i th 
morphometric analysis  between laparoscopic and 
open CME (95); specimen quality was not statistically 
significantly different although there were concerns about 
the quality of laparoscopic resection for hepatic flexure and 
transverse colon tumors (shorter length from the tumor to 
the vascular tie, fewer lymph nodes harvested and a shorter 
bowel resection).
Lymph node yield
West et al.  (94) observed that, compared with the 
conventional operation for colon cancer, CME was 
associated with more lymph nodes being removed and 
analyzed.
In the ADC study (57), the median lymph node count 
was 15 (range, 0–113). R0 status was confirmed in 883/905 
patients (97.6%; 95% CI: 96.4–98.5). As noted previously, 
results can be considered as robust because of the narrow 
width of the confidence intervals.
Anatomically correct D3 resection according to the 
“D3 space” (45,46) implies posterior vertical compartment 
removal, technically more challenging when the ileocolic 
artery crosses the superior mesenteric vein posteriorly. 
According to these studies, addition of the lateral vertical 
compartment lymphadenectomy increases the lymph node 
yield by 5 to 6 nodes. 
In their systematic review, Gouvas et al. (96) found that 
CME produced a longer central pedicle that contained more 
lymph nodes than conventional surgery for colon cancer, 
but, as others, concluded that there is limited evidence that 
CME improves long-term oncological outcomes.
For tumors located in the right colon, the lymph nodes 
along the ileum, right colon and the root of the middle 
colon vessels should be completely dissected (97). For 
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tumors located at the hepatic flexure, the lymph node-
positive rate at the head of the pancreas and gastric curvature 
has been reported to be 5% and 4%, respectively (97). 
Therefore, extended resection should transect the right 
gastro-epiploic vein to remove lymph node station 6 and 
divide and remove the gastroepiploic arteries along the 
greater curvature of stomach, i.e., 10–15 cm away from the 
resected tumor along the gastro-epiploic arcade (97).
In their systematic review (98), Bertelsen et al. were not 
able to find any statistically significant relationship between 
extended lymph node dissection and better oncological 
outcome.
The non-randomized comparative study by Kim et al. (68) 
found that pathologic (specimen lengths, resection margin 
distance, number of lymph nodes, and R0 resection) and 
oncologic outcomes of the laparoscopic CME group were 
comparable to open CME. 
In the recent series of 600 consecutive patients 
undergoing laparoscopic right colectomy with CME, Siani 
et al. (90) found that survival was poor (27.7%) when the 
apical nodes were positive. 
In summary, CME has been found to be associated 
with high disease-free survival in patients with stage I–III 
colon adenocarcinoma in several studies (57,90,91), but 
causality cannot be inferred as truly unbiased comparisons 
to “conventional” techniques, taking into account all 
confounding factors, are lacking. Moreover, no inter-
observer or intra-observer validation of outcomes was 
available.
Notwithstanding several papers describing the lymph 
node anatomy [most being cadaveric (45,46)], and the 
feasibility of extended lymph node retrieval via laparoscopy 
or robotic approaches, further controlled studies are needed 
to show that the increased lymph node removal in CME 
leads to improved prognosis, less local recurrence and better 
overall survival (98) in unbiased high-quality research (96). 
How does CME fare compared to D3 resections?
Consensus
Number of answers =14
	 Better lymph node yield (4 yes/10 no)
	 Extended length of resection (7 yes/7 no)
	 Better staging (2 yes/12 no)?
	 Lower local recurrence rates (3 yes/11 no)?
	 Improved survival (3 yes/11 no)?
Literature review
Japanese surgeons have advocated central node dissection 
for many years (99). According to the Japanese guidelines, 
D3 dissection is based on anatomical lymph node dissection 
at the root of the tumor-feeding artery, and the longitudinal 
length of large bowel to be resected is determined according 
to the location of the tumor in relation to the feeding 
artery (100). CME requires the same high ligation of 
corresponding vessels and thorough lymph node dissection, 
as described in D3 resection (14). Moreover, CME puts the 
emphasis on preservation of anatomic (embryonic) planes 
with intact mesenteric fascia to which one adds CVL (12). 
The D3 Japanese guidelines follow the 5–10 cm rule to 
determine the extent of associated bowel length whereas the 
length of bowel resected in CME is determined according 
to the vascular territory (2). While these two techniques 
differ in their concept, and essentially in the extent of bowel 
resection, they have the same purpose (67,69,96).
Paquette et al. performed a literature search to determine 
the survival benefit of proximal vascular ligation colon 
cancer and made pertinent differentiations between the 
two techniques [Japanese Society of Cancer of the Colon 
and Rectum recommendations (2) and CME combined 
with CVL] (101) with regard to the extent of lymph node 
dissection. The D3 dissection includes the lymph nodes 
along (D2) as well as those at the junction and along the 
root vessel. This means that D3 dissection for right-sided 
tumors includes lymph nodes along the anterior aspect 
of the SMV and SMA (central lymph nodes) and for left-
sided tumors includes lymph nodes around the inferior 
mesenteric artery (IMA) while CME and CVL implies 
complete dissection of the lympho-adipose tissue around 
the SMV and SMA for right sided tumors (after Kocher 
maneuver and takedown of the mesenteric attachments 
to the duodenum and uncinate process of the pancreas), 
removal of the gastro-epiploic lymph nodes for tumors 
of the hepatic flexure, and central ligation of the middle 
colic and right gastroepiploic vessels (with preservation 
of the pancreaticoduodenal artery) for transverse colon 
tumors (12). The precisions regarding lymph node 
dissection around and behind the origin of the middle colic 
and ileocolic vessels proposed by Spasojevic (45,46) remains 
to be added to these lymph node protocols.
West et al. compared the specimens of CME (from 
Erlangen, Germany) to D3 resections (from Tokyo Medical 
and Dental University and the Tokyo Metropolitan 
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Komagome Hospital) (94) and found that, although the 
mesocolic plane resection rates were high in all series, 
the Japanese D3 specimens were statistically significantly 
shorter (162 vs. 324 mm, P<0.001), resulting in a statistically 
significantly smaller amount of mesentery (8.3 vs. 18.0 mm2, 
P<0.001) and nodal yield (median, 18 vs. 32, P<0.001), while 
the difference in the distance between the high vascular tie 
and the bowel wall (100 vs. 99 mm) was not found to be 
statistically significant (P=0.605).
In fact, as the definitions of D2, D3 and CME differ 
somewhat in the literature, it is difficult to understand 
what the real differences are from the technical viewpoint. 
Some teams do not make any distinction between the two 
(14,15,69). Lu et al. on the other hand, defined CME as D2 
plus removal of the lymphatic and adipose tissue and not 
only the connective tissues around the SMA but include 
removal of the whole anterior and posterior aspects of the 
mesocolon and the lymphoadipose tissues covering the 
anterior surface of the pancreatic head and neck (102). 
Again, one of the best definitions of the distinction between 
the two is provided in the review article by Paquette 
et al. (101).
Are there specific indications for CME?
Consensus
Number of answers =13
	 For all locations (10 yes/3 no)
	 Right-sided (12 yes/1 no)
	 Transverse (including flexures) (12 yes/1 no)
	 Left-sided (not sure 13)
Number of answers =9
	 For all stages? (4 yes/5 no)
	 If no which______________
for metastatic colon cancer, not for early stage, only for 
clinical stage II & III and IV with curative intent, stage IV 
should be excluded, only for stage II and III.
Literature review
The 2005 Japanese practice guidelines recommended 
dissecting Group 3 nodes for cStage II or III colorectal 
cancer patients (97,99), and since that date, a nation-wide 
survey of the proportion of patients who underwent D3 LN 
dissection among Stage II/III patients with CRC found a 
steady increase in the uptake of the D3 procedure.
In 2012, the Japanese Society for Cancer of the Colon 
and Rectum (JSCCR) (2) proposed the surgical indications 
of D3 dissection in its guidelines on the treatment of 
colorectal cancer as follows (2): D3 lymph node dissection 
should be performed in patients with lymph node metastasis 
recognized before or during the surgery or if pre- or intra-
operative evaluation indicates that the tumor infiltration has 
reached the proper muscular layer or deeper. 
In 2010, the Chinese Guidelines on the Diagnosis and 
Treatment of Colorectal Cancer (issued by the Chinese 
Ministry of Health) (103) also indicated that D3 lymph 
node dissection should be performed for T2-4N0-2M0 colon 
cancer. In contrast, CME can be proposed for all stages, 
T1-4, Nx, M0.
Although it has never been shown formally, some Asian 
authors claim that D3 colectomy provides better survival in 
patients with T3 and T4 colonic cancer (104). Whether this 
can be extended to CME remains to be shown. For Storli 
et al. (105), survival was improved even for node negative 
disease (TNM stages 1 and 2): 3 year overall survival and 
disease free survival was statistically superior in patients 
undergoing CME vs. “mid-mesenteric” or D2 colectomy 
(88.1% vs. 79 %, and 82.1% vs. 74.3%, respectively). Of 
note, however, in-hospital postoperative mortality was high 
(8.6% vs. 2.8%) in the D2 colectomy group, perhaps biasing 
long-term survival, there was an obvious selection bias in 
patients undergoing CME, the study was retrospective 
and lymph node retrieval for D2 colectomy may have 
differed between the two hospitals. Moreover, there were 
no statistically significant differences in local or overall 
recurrence between the groups.
According to West et al. (25), CME could be expected to 
be most important and extend long-term survival in patients 
with positive lymph node findings for stage III colon cancer.
Søndenaa et al., in their 2014 consensus statement (17), 
proposed that while “there are sound oncological 
hypotheses for a more radical approach [to colonic cancer] 
than has been common up to now”, “however, this may not 
necessarily apply in early stages of the tumour stage.”
Several authors have found that up to 5–11% of colon 
cancer patients have central lymph node metastasis, among 
which 0.8% may be skip metastasis (106,107). In terms 
of lymph node characteristics, micrometastases (<2 mm) 
and free clusters (<0.2 mm) of tumor cells can exist within 
the colonic mesentery lymph nodes (108). Furthermore, 
1–5 micrometastases may be found in a single tumor 
specimen. This may explain why some authors have found 
increased survival in N0 patients undergoing extended 
lymph node resection (109,110). In their recent non-
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comparative series of 600 consecutive patients, Siani 
et al. (90) found that while overall survival was 83%, 
survival in stage II, IIIA/B and in stage IIIC with negative 
apical nodes was 88.7%, 72.4%, and 71.4%, respectively. 
Conversely, survival was 27.7% in stage IIIC patients when 
the apical nodes were positive, suggesting once again that 
CME may not be the entire answer. 
What are the future perspectives for CME? 
Literature review
In view of the morbidity associated with extended 
mesenteric resection, and the absence of formal proof of 
carcinological improvement, further trials are necessary 
to define if there is a specific population that might best 
benefit from extended resections.
Several other studies are underway. The objectives of 
the T-REX study (International Prospective Observational 
Cohort Study for Optimal Bowel Resection Extent and 
Central Radicality for colon cancer) (111) are to clarify 
the actual status of metastatic LN distribution in colon 
cancer and also provide reliable evidence regarding the 
optimal length of bowel resection and the extent of central 
LN dissection (secondary endpoints). Currently underway 
(1,410 patients recruited up to November 2016) the goal is 
to include 4,000 patients between May 30, 2013 and Dec 
31, 2017. Results are awaited in 2018.
The RELARC randomized tr ia l  (102)  a ims to 
investigate whether laparoscopic colectomy with extended 
lymphadenectomy (CME) could improve the oncological 
outcomes of patients with right-sided colon cancers, 
compared with D2 lymphadenectomy. This superiority, 
prospective, multicenter, randomized, two-arm, parallel-
group, single-blind clinical trial is expected to last 7 years, 
including 4 years for recruiting patients and 3 years for 
follow-up.
Other unanswered questions include: should 3D vascular 
mapping be mandatory before extended D3 resection 
(32, 34,112)? The extreme anatomic vascular variability and 
the danger that can arise when the GCT of Henlé is injured 
might well justify the precaution (32,46). Additionally, if 
one admits that one of the key points of CME is to try to 
eliminate all lymph node deposits, then there may be a role 
for Indocyanine Green enhanced fluorescence to identify 
metastatic lymph nodes during operation. Ozben et al. (113) 
and Nishigori et al. (114) have described the technique 
of lymph node dissection under the control of real-time 
visualization of the lymph nodes and lymphatic circulation 
to ensure complete metastatic lymph node clearance during 
CME. This can be performed with the robotic system as 
well as with conventional laparoscopy. Indocyanine green 
angiography may have an increasing role in colorectal 
surgery, not only to map the vascular territories and their 
distribution but also to ensure the adequate vascularity of 
the distal, and sometimes also, the proximal segments to 
be anastomosed (115,116). Johnson et al. described their 
experience in 2016 (117) concluding that fluorescence 
angiography may provide helpful information when the 
status of one of the major colonic vessels is unknown or 
impaired.
Can CME be considered the gold standard in 
2017?
Consensus
Number of answers =14 (10 yes/4 no)
Literature review
CME can  be  pe r fo rmed  e i the r  v i a  l apa ro tomy, 
laparoscopically or with single port or robotically-assisted 
techniques. Technical advances (high-magnification and 
resolution-based images) have underscored the possibility 
and the importance of adhering to fundamental surgical 
planes in order to perform a safe and effective surgery. 
Surgical specimens can meet the pathological requirements 
for radical treatment. Although further studies are 
warranted to identify the potential advantages (e.g., long-
term efficacy) of CME for colorectal cancer, it, even as a 
concept, has the potential to promote the improvement and 
standardization of surgical techniques (47). As was the case 
a few decades ago, the concept and the practice of TME 
was adapted widely without formal proof that it improved 
cancer outcomes. Even if no one today would challenge 
the concept, the technique, or the outcomes published, the 
results observed may not be anything more than a pseudo 
“Hawthorne” effect (we do things with more application 
because we have been told that it works). If improved 
overall survival for CME can be shown across the board, in 
the same way as happened for TME, it may indeed be the 
beginning of a new era in the radical treatment of colonic 
cancer.
In accordance with Willaert and Celen (118) there is no 
high quality evidence to advocate routine implementation 
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of CME. The reasons are (I) local recurrence may result 
from systemic disease, more often than from incompletely 
removed lymph nodes; (II) there is no proof that higher 
nodal counts improve outcome; (III) metastasis to 
locoregional nodes probably occurs early and is stochastic 
rather than stepwise.
However, in harmony with the tenors of open CME 
(9,12), and as stated by Kim et al. (68), because of fewer 
postoperative complications, reduced time to soft diet, and 
reduced length of hospital stay, laparoscopic CME could 
be considered as a routine elective approach for right-sided 
colon cancer, if indeed, improved survival and/or less local 
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